Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Credit Suisse High Yield Bond Fund | DHY | Nov 14, 2024 | 2.15 | +0.47 |
Credo Technology | CRDO | Nov 14, 2024 | 41.90 | -8.65 |
Crescent Capital BDC | CCAP | Nov 14, 2024 | 19.13 | +1.86 |
Crescent Energy | CRGY | Nov 14, 2024 | 13.99 | +1.38 |
Cresud A ADR | CRESY | Nov 14, 2024 | 10.85 | +2.55 |
Crexendo | CXDO | Nov 14, 2024 | 5.11 | -2.67 |
CRH | CRH | Nov 14, 2024 | 99.87 | +0.70 |
Cricut A | CRCT | Nov 14, 2024 | 5.17 | -6.68 |
Crinetics Pharmaceuticals | CRNX | Nov 14, 2024 | 59.66 | +1.26 |
CRISPR Therapeutics | CRSP | Nov 14, 2024 | 46.85 | -5.90 |
Criteo ADR | CRTO | Nov 14, 2024 | 37.92 | +1.91 |
Critical Metals | CRML | Nov 14, 2024 | 6.03 | -3.83 |
Crocs | CROX | Nov 14, 2024 | 99.86 | +0.91 |
Cronos Group | CRON | Nov 14, 2024 | 2.07 | -4.61 |
Cross Country Healthcare | CCRN | Nov 14, 2024 | 10.01 | -0.89 |
Cross Timbers Royalty Royalty Trust | CRT | Nov 14, 2024 | 10.03 | -0.10 |
CrossAmerica Partners LP Unit | CAPL | Nov 14, 2024 | 20.14 | -0.30 |
CrossFirst Bankshares | CFB | Nov 14, 2024 | 17.27 | -0.46 |
CrowdStrike A | CRWD | Nov 14, 2024 | 344.36 | -1.01 |
Crown Castle | CCI | Nov 14, 2024 | 102.92 | +0.16 |
Crown Crafts | CRWS | Nov 14, 2024 | 4.54 | +2.25 |
Crown ElectroKinetics | CRKN | Nov 14, 2024 | 0.92 | -4.19 |
Crown Holdings | CCK | Nov 14, 2024 | 90.06 | -2.37 |
Crown LNG | CGBS | Nov 14, 2024 | 0.47 | -15.95 |
Cryo-Cell International | CCEL | Nov 14, 2024 | 8.73 | -4.80 |
CryoPort | CYRX | Nov 14, 2024 | 7.38 | -3.78 |
CS Disco | LAW | Nov 14, 2024 | 5.68 | -2.57 |
CSG Systems International | CSGS | Nov 14, 2024 | 54.48 | -1.47 |
CSP | CSPI | Nov 14, 2024 | 12.98 | +2.93 |
CSW Industrials | CSWI | Nov 14, 2024 | 407.79 | -1.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.